Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Saxagliptin is a potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor designed for once-daily use. It is indicated for improving glycemic control in patients with type 2 diabetes (T2D).
Saxagliptin works by inhibiting CD26 (Dipeptidyl peptidase 4) (DPP4), which increases and prolongs the effects of incretins such as glucagon-like peptide-1 (GLP-1) and [gastric inhibitory polypeptide (GIP)]…